Position in TMO
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$636,225
+$1,169 QoQ
Shares Held
1,269
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,641
of 2,606 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Apella Capital, LLC holds $1,459,432 across 4 Diagnostics & Research names. TMO ranks #1 (43.6% of the industry book) .
All Filings in TMO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $636,225 | 1,269 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $635,056 | 1,292 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $431,110 | 744 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $352,124 | 726 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $259,494 | 640 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $298,560 | 600 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $282,484 | 543 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $332,790 | 538 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $274,288 | 496 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $288,861 | 497 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $262,210 | 494 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $250,047 | 494 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $257,222 | 493 | Shares | Sole | 2023-07-06 | |
| 2022-12-31 | $249,462 | 453 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $219,613 | 433 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $219,485 | 404 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $212,043 | 359 | Shares | Sole | 2022-04-11 | |
| No filing history on record for this holder in this stock. | ||||||